The SIOPE Brain Tumour Group’s Low-Grade Glioma (LGG) Working Group welcomes new members to join a vibrant, pan-European, multidisciplinary community dedicated to improving outcomes for children and adolescents with LGG—the most common pediatric brain tumours, and the reason our working group is the largest within SIOPE BTG. We currently bring together 123 clinicians and scientists from across Europe — pediatric oncologists, neurosurgeons, radiation oncologists, ophthalmologists, pathologists, biologists, endocrinologists, neuropsychologists, radiologists, and others — who diagnose, treat, and study pediatric LGG.

Our mission is to advance diagnosis and therapy through coordinated basic, translational, and clinical research, and to accelerate practice-changing collaborations. The working group is organised into active subgroups that tackle key needs: LGG in infants (lead: Amedeo Azizi), LGG in NF1 (lead: Astrid Sehested), disseminated LGG (lead: Michal Zapotocky), LGG in AYA (lead: Netteke Schouten), radiotherapy in LGG (lead: Semi Harrabi), and bevacizumab in LGG (lead: Enrico Opocher). In addition to our in-person annual meeting alongside the SIOPE BTG conference, we convene two virtual meetings each year to share ongoing studies, clinical-trial readouts, clinical cases and new collaborative ideas — including sessions open to invited guests. Co-chaired by Till Milde and Álvaro Lassaletta, the LGG Working Group offers a practical platform to connect with peers, launch multicentre projects, and shape future standards of care.

If you share this mission, we would be delighted to have you on board—please reach out to join and help us move the field forward together.”